This effort to accelerate development can be clearly seen in how the agency is approaching biosimilars. In October 2025, the FDA issued a guidance update indicating that “switching” studies — a trial ...
Abstract: The sensor nodes in wireless sensor networks (WSNs) are deployed randomly in structured, unstructured, or harsh environments. The measured or sensed data by sensors is meaningful only if its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback